Health Economics and Outcomes Research (HEOR) as a tool for improving operational performance and competitive advantage

ESiOR Ltd provides companies, service providers and other entities operating in social care and healthcare with expert solutions, services, tools and consulting to aid decision making, management and marketing. Our expert services provide the means to identify, demonstrate, communicate and improve the competitiveness of products, services, processes and networks.

Benefit from our competence

ESiOR has considerable expertise and extensive experience in the key methods, solutions and approaches that enable knowledge management and competitive differentiation.

Our areas of expertize

  • social and health economics
  • pharmacoeconomics
  • statistics
  • visualization
  • outcomes research
  • economic evaluation
  • health technology assessments (HTA)
  • cost-effectiveness analyses
  • budget impact tools
  • mathematical modelling
  • goal setting
  • data management
  • reporting
  • publishing.

The full scope of our services varies from consulting to turnkey solutions encompassing design, analysis, model development, reporting, publication and communication.

We specialize in:

  • commissioned research
  • registry studies
  • systematic literature reviews and meta-analysis
  • data-analysis
  • health economic evaluations
  • local and global modelling and model development
  • localizations and country adaptations for global health economic models.

In addition to health economic evaluations, we now offer Market Access services. These include, among others, all pricing and reimbursement applications and comprehensive consultancy.

From data to competitive advantage

The characteristics of products, services, programmes and networks can be made to stand out and they can be differentiated from their competitors with a unique selling point.

Sources for distinctive advantages:

  • customer experience
  • quality
  • productivity
  • profitability
  • effectiveness
  • quality of life
  • costs
  • cost containment
  • target attainment
  • budget impact
  • cost-effectiveness
  • key performance indicators (KPI)
  • other outcomes.

Differentiation is an essential part of having a competitive advantage.

News:

Welcome Tuomas Lundström

ESiOR Oy experience is increasing… We welcome the 12th member of our team. Tuomas Lundström has joined our team as consultant and data scientist. Tuomas has background from psychology added with statistics know-how. His area of expertise includes R and Python programs, which makes our analytics expertise even stronger for the best of our clients. […]

See more

Publications:

Cost-effectiveness and budget impact analysis including a risk-sharing scheme

Conditional reimbursement context: An economic evaluation including a risk-sharing scheme A hybrid-modeling study that evaluated the clinical outcomes, cost-effectiveness, and budget impact of biologic rheumatoid arthritis drugs as a treatment mix and individually for biologic-naïve patients in Finland has been recently published. The assessment includes also certolizumab pegol with and without a hypothetical efficacy-based risk-sharing […]

See more